These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23855817)

  • 1. New therapy options for amyotrophic lateral sclerosis.
    Gordon P; Corcia P; Meininger V
    Expert Opin Pharmacother; 2013 Oct; 14(14):1907-17. PubMed ID: 23855817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M; Kwiecinski H
    Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding ALS: new therapeutic approaches.
    Musarò A
    FEBS J; 2013 Sep; 280(17):4315-22. PubMed ID: 23217177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future.
    Harikrishnareddy D; Misra S; Upadhyay S; Modi M; Medhi B
    Rev Neurosci; 2015; 26(2):161-81. PubMed ID: 25720096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for amyotrophic lateral sclerosis.
    Habib AA; Mitsumoto H
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):537-58. PubMed ID: 21806316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).
    Poppe L; Rué L; Robberecht W; Van Den Bosch L
    Exp Neurol; 2014 Dec; 262 Pt B():138-51. PubMed ID: 25017368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J
    Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis.
    Srivastava AK
    Neurol India; 2014; 62(3):239-48. PubMed ID: 25033844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic development in amyotrophic lateral sclerosis.
    Bucchia M; Ramirez A; Parente V; Simone C; Nizzardo M; Magri F; Dametti S; Corti S
    Clin Ther; 2015 Mar; 37(3):668-80. PubMed ID: 25666449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic.
    Mancuso R; Navarro X
    Prog Neurobiol; 2015 Oct; 133():1-26. PubMed ID: 26253783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis: an update.
    de Carvalho M; Swash M
    Curr Opin Neurol; 2011 Oct; 24(5):497-503. PubMed ID: 21725240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis--the tools of the trait.
    Lederer CW; Santama N
    Biotechnol J; 2007 May; 2(5):608-21. PubMed ID: 17345579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.